Literature DB >> 21958435

Staging of laryngeal carcinoma: comparison of high-frequency sonography and contrast-enhanced computed tomography.

Q Hu1, F Luo, S Y Zhu, Z Zhang, Y P Mao, X Hui Guan.   

Abstract

AIM: To evaluate the accuracy of high-frequency sonography on pretherapeutic T-staging in patients with laryngeal carcinoma.
MATERIALS AND METHODS: Thirty-six consecutive patients with laryngeal carcinoma undergoing surgical resection were included in this study. All patients underwent ultrasonographic examination and contrast-enhanced computed tomography before surgery. These imaging interpretations were evaluated independently and then compared with the reference of postoperative pathological examination. McNemar's test was used for comparing the data obtained separately from ultrasonography and computed tomography.
RESULTS: There was one T2 stage tumour of an aryepiglottic fold undetected by sonography. Sonography failed to stage five tumours correctly; the T-staging accuracy was 83.3%. Contrast-enhanced computed tomography failed to stage four patients correctly; the T-staging accuracy was 88.8%. There was no difference between the pretherapeutic staging accuracy of ultrasonography and contrast-enhanced computed tomography (p=0.735).
CONCLUSION: Ultrasonography has a reliable pretherapeutic staging accuracy of laryngeal carcinoma. It can be a non-invasive complementary technique for pretherapeutic staging of laryngeal carcinoma.
Copyright © 2011 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21958435     DOI: 10.1016/j.crad.2011.08.010

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  3 in total

1.  Usefulness of ultrasonography in assessment of laryngeal carcinoma.

Authors:  C-X Xia; Q Zhu; H-X Zhao; F Yan; S-L Li; S-M Zhang
Journal:  Br J Radiol       Date:  2013-09-04       Impact factor: 3.039

2.  MicroRNA-133a suppresses the proliferation, migration, and invasion of laryngeal carcinoma cells by targeting CD47.

Authors:  Hui Li; Yan Wang; Yan-Zhong Li
Journal:  Tumour Biol       Date:  2016-10-11

3.  Clinical value of (dedicated) 3 Tesla and 7 Tesla MRI for cT1 glottic carcinoma: A feasibility study.

Authors:  Sylvia L van Egmond; Bernard M D Vonck; Johanna J Bluemink; Frank A Pameijer; Jan Willem Dankbaar; Inge Stegeman; Marielle E P Philippens; Cornelis A T van den Berg; Luuk M Janssen; Chris H Terhaard
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-01-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.